Clarity on which technology and regulatory projects will deliver the vision for the future.
Conduct more detailed design and engineering to show value of NIIMBL projects.
Detailed business case for integrated continuous bioprocessing (ICB) with capital cost estimates.
Line of sight from corporate manufacturing goals to NIIMBL projects.
Login to the NIIMBL member portal to access more, including:
Not yet a member? Learn more about which level of NIIMBL membership is right for you and your organization.
NIIMBL
Amgen Inc.
AstraZeneca
Bristol-Myers Squibb
CSL Behring, LLC
Cytiva
Eli Lilly and Company
Genentech, Inc.
GlaxoSmithKline, LLC
IPS-Integrated Project Services, LLC
Janssen Research & Development, LLC
Merck Sharp & Dohme LLC
MilliporeSigma/EMD Serono
Pfizer, Inc.
Sanofi
Sartorius Stedim
Takeda Pharmaceuticals